

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 6.68814820 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.12962939 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 5.82976022 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.59589241 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.35955976 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.34573976 |
| 7 | regulation of B cell differentiation (GO:0045577) | 5.25786653 |
| 8 | detection of other organism (GO:0098543) | 5.19256445 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.16934865 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.16934865 |
| 11 | detection of bacterium (GO:0016045) | 5.05642345 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 4.94733765 |
| 13 | respiratory burst (GO:0045730) | 4.83080311 |
| 14 | cellular response to zinc ion (GO:0071294) | 4.58336282 |
| 15 | neutrophil activation (GO:0042119) | 4.57889908 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.38233221 |
| 17 | detection of external biotic stimulus (GO:0098581) | 4.34146271 |
| 18 | leukocyte aggregation (GO:0070486) | 4.34131792 |
| 19 | positive regulation of mast cell degranulation (GO:0043306) | 4.26819791 |
| 20 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.26819791 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19081790 |
| 22 | granulocyte activation (GO:0036230) | 4.18804884 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15873474 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.14799755 |
| 25 | positive regulation of mast cell activation (GO:0033005) | 4.14334257 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.09682184 |
| 27 | cellular extravasation (GO:0045123) | 4.07506961 |
| 28 | response to peptidoglycan (GO:0032494) | 4.06718907 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.04080402 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 4.02657317 |
| 31 | neutrophil mediated immunity (GO:0002446) | 3.99431339 |
| 32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.92207497 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.92120086 |
| 34 | response to host (GO:0075136) | 3.92120086 |
| 35 | response to host defenses (GO:0052200) | 3.92120086 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.91571779 |
| 37 | microglial cell activation (GO:0001774) | 3.84783410 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84071641 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.84071641 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84071641 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84071641 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84071641 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.84071641 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.82228330 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81059294 |
| 46 | defense response to fungus (GO:0050832) | 3.79162715 |
| 47 | response to fungus (GO:0009620) | 3.76272864 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67957303 |
| 49 | regulation of superoxide anion generation (GO:0032928) | 3.66761950 |
| 50 | defense response to protozoan (GO:0042832) | 3.60833885 |
| 51 | macrophage activation (GO:0042116) | 3.60158946 |
| 52 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.59724342 |
| 53 | regulation of mast cell activation (GO:0033003) | 3.58974206 |
| 54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.55887588 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53300743 |
| 56 | response to interleukin-15 (GO:0070672) | 3.52297301 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.46158559 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46158559 |
| 59 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40285209 |
| 60 | mature B cell differentiation (GO:0002335) | 3.37985163 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.36849539 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.36849539 |
| 63 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.35901637 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.35720155 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.35168548 |
| 66 | response to type I interferon (GO:0034340) | 3.34933368 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31880055 |
| 68 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.29721006 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.29659262 |
| 70 | leukotriene biosynthetic process (GO:0019370) | 3.25340026 |
| 71 | response to protozoan (GO:0001562) | 3.24432676 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 3.23633728 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.22037922 |
| 74 | leukocyte degranulation (GO:0043299) | 3.20775688 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20749776 |
| 76 | adaptation of signaling pathway (GO:0023058) | 3.17732784 |
| 77 | B cell proliferation (GO:0042100) | 3.15043995 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 3.14640373 |
| 79 | negative regulation of B cell proliferation (GO:0030889) | 3.14397032 |
| 80 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.14327033 |
| 81 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.14327033 |
| 82 | leukotriene metabolic process (GO:0006691) | 3.10528270 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10205447 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 3.09205220 |
| 85 | positive regulation of antigen processing and presentation (GO:0002579) | 3.08190570 |
| 86 | response to muramyl dipeptide (GO:0032495) | 3.07159149 |
| 87 | T cell homeostasis (GO:0043029) | 3.07138200 |
| 88 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05242527 |
| 89 | positive regulation of leukocyte degranulation (GO:0043302) | 3.04677916 |
| 90 | pentose-phosphate shunt (GO:0006098) | 3.02798352 |
| 91 | lymphocyte homeostasis (GO:0002260) | 3.01370153 |
| 92 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.00184903 |
| 93 | myeloid leukocyte mediated immunity (GO:0002444) | 2.98316889 |
| 94 | B cell mediated immunity (GO:0019724) | 2.96691520 |
| 95 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.96503879 |
| 96 | negative regulation of interleukin-6 production (GO:0032715) | 2.96337614 |
| 97 | mannose metabolic process (GO:0006013) | 2.96220311 |
| 98 | positive regulation of interferon-alpha production (GO:0032727) | 2.96078779 |
| 99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95787802 |
| 100 | regulation of regulated secretory pathway (GO:1903305) | 2.95072348 |
| 101 | negative regulation of innate immune response (GO:0045824) | 2.93774492 |
| 102 | regulation of B cell apoptotic process (GO:0002902) | 2.93181255 |
| 103 | B cell homeostasis (GO:0001782) | 2.92090695 |
| 104 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92071476 |
| 105 | NIK/NF-kappaB signaling (GO:0038061) | 2.91316457 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91213192 |
| 107 | leukocyte mediated cytotoxicity (GO:0001909) | 2.90930321 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90528958 |
| 109 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.90425632 |
| 110 | neutrophil chemotaxis (GO:0030593) | 2.89589164 |
| 111 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89543384 |
| 112 | negative regulation of granulocyte differentiation (GO:0030853) | 2.89511542 |
| 113 | tolerance induction (GO:0002507) | 2.88252623 |
| 114 | leukocyte cell-cell adhesion (GO:0007159) | 2.87031505 |
| 115 | germinal center formation (GO:0002467) | 2.86440002 |
| 116 | myeloid leukocyte activation (GO:0002274) | 2.85418300 |
| 117 | T cell migration (GO:0072678) | 2.85176966 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84808444 |
| 119 | T-helper 1 type immune response (GO:0042088) | 2.83589886 |
| 120 | regulation of B cell proliferation (GO:0030888) | 2.83524133 |
| 121 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.82999226 |
| 122 | negative thymic T cell selection (GO:0045060) | 2.82938185 |
| 123 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.81978522 |
| 124 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.81978522 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.81871135 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.81699028 |
| 127 | neutrophil migration (GO:1990266) | 2.81111218 |
| 128 | mature B cell differentiation involved in immune response (GO:0002313) | 2.80732954 |
| 129 | regulation of interferon-alpha production (GO:0032647) | 2.79814731 |
| 130 | regulation of phagocytosis (GO:0050764) | 2.78547645 |
| 131 | positive regulation of B cell activation (GO:0050871) | 2.77068937 |
| 132 | natural killer cell differentiation (GO:0001779) | 2.76437426 |
| 133 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76029513 |
| 134 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.74453775 |
| 135 | negative regulation of interleukin-12 production (GO:0032695) | 2.73723668 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.71247311 |
| 137 | response to host immune response (GO:0052572) | 2.71247311 |
| 138 | positive thymic T cell selection (GO:0045059) | 2.71028306 |
| 139 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.70846920 |
| 140 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.70846920 |
| 141 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.70846920 |
| 142 | mast cell activation (GO:0045576) | 2.69928275 |
| 143 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69526570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.74759775 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.61353645 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.13638045 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.93061306 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.68741762 |
| 6 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.66674568 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.40880325 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.37112606 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10828242 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02621832 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88221668 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86328326 |
| 13 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84373245 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76006700 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65363986 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.55731913 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53253861 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.52960893 |
| 19 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.51779769 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.48744504 |
| 21 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.45000609 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41639648 |
| 23 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.41246417 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.39682476 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38414807 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.34541464 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.26425976 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.21743796 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.14368135 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13785995 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12565116 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.11157894 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05781276 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97492085 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96912776 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91449221 |
| 37 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.82064539 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81068060 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80210296 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75599920 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74162631 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72036802 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71872310 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67554776 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62936404 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62807493 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.62501398 |
| 48 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60622339 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60198754 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55054007 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54124266 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52637328 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52228804 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.51098349 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50448872 |
| 56 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50304570 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49666283 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49054269 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48457581 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44883317 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38592179 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38200957 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35311645 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34659441 |
| 65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33352035 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31689298 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29499888 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27758003 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26423985 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25101515 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23417146 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23077356 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21645895 |
| 74 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19479475 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18293889 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18266692 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14761616 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14187375 |
| 79 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14058106 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12064834 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11865099 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.11474891 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11468326 |
| 84 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11275873 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10878240 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08998523 |
| 87 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.07275147 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06642029 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06372671 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05168293 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01931227 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01222029 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98832781 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96891183 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96183480 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92972344 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92887851 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91750948 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 0.89642977 |
| 100 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89302529 |
| 101 | P300_27268052_Chip-Seq_Bcells_Human | 0.89000073 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88749328 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88255350 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88248678 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87580346 |
| 106 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87334150 |
| 107 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87276400 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87081120 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86816455 |
| 110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86445520 |
| 111 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85793195 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85183271 |
| 113 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83860410 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82297620 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80735732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.56645928 |
| 2 | MP0003303_peritoneal_inflammation | 4.25144372 |
| 3 | MP0001800_abnormal_humoral_immune | 3.76413248 |
| 4 | MP0001790_abnormal_immune_system | 3.69937391 |
| 5 | MP0005387_immune_system_phenotype | 3.69937391 |
| 6 | MP0003436_decreased_susceptibility_to | 3.43531830 |
| 7 | MP0000685_abnormal_immune_system | 3.29423984 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.21223827 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.03740239 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.80933423 |
| 11 | MP0009785_altered_susceptibility_to | 2.78765635 |
| 12 | MP0002419_abnormal_innate_immunity | 2.78157130 |
| 13 | MP0002723_abnormal_immune_serum | 2.77586377 |
| 14 | MP0001819_abnormal_immune_cell | 2.75771581 |
| 15 | MP0005025_abnormal_response_to | 2.62992160 |
| 16 | MP0002398_abnormal_bone_marrow | 2.54592717 |
| 17 | MP0005671_abnormal_response_to | 2.45445073 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.40527804 |
| 19 | * MP0000716_abnormal_immune_system | 2.36250221 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.33304527 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.31136700 |
| 22 | MP0009278_abnormal_bone_marrow | 2.27222969 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.11777592 |
| 24 | MP0004808_abnormal_hematopoietic_stem | 2.07603659 |
| 25 | MP0002722_abnormal_immune_system | 2.04393176 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.03192942 |
| 27 | * MP0002429_abnormal_blood_cell | 1.99692553 |
| 28 | MP0002405_respiratory_system_inflammati | 1.98101681 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.94525471 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.86537724 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.86101322 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.84623466 |
| 33 | MP0001853_heart_inflammation | 1.79881052 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.73819296 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.73819296 |
| 36 | MP0001873_stomach_inflammation | 1.69528001 |
| 37 | MP0004510_myositis | 1.69360494 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.69342739 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.65935627 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.65162910 |
| 41 | MP0004947_skin_inflammation | 1.57623237 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.53023541 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.50248373 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.49270637 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.48666359 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.47132310 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.44459412 |
| 48 | MP0005451_abnormal_body_composition | 1.42507965 |
| 49 | MP0003724_increased_susceptibility_to | 1.37694918 |
| 50 | MP0002933_joint_inflammation | 1.37565791 |
| 51 | MP0002006_tumorigenesis | 1.33143252 |
| 52 | MP0000490_abnormal_crypts_of | 1.27187968 |
| 53 | MP0008469_abnormal_protein_level | 1.25898352 |
| 54 | MP0006054_spinal_hemorrhage | 1.23176979 |
| 55 | MP0006082_CNS_inflammation | 1.18902961 |
| 56 | MP0009840_abnormal_foam_cell | 1.17432292 |
| 57 | MP0003866_abnormal_defecation | 1.16923253 |
| 58 | MP0005310_abnormal_salivary_gland | 1.14292709 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.09979756 |
| 60 | MP0004883_abnormal_blood_vessel | 1.09558853 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.09130505 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.06786472 |
| 63 | * MP0002019_abnormal_tumor_incidence | 1.06278383 |
| 64 | MP0010307_abnormal_tumor_latency | 1.03146353 |
| 65 | MP0004381_abnormal_hair_follicle | 1.01274697 |
| 66 | MP0005076_abnormal_cell_differentiation | 0.99856660 |
| 67 | MP0003075_altered_response_to | 0.99226664 |
| 68 | MP0003693_abnormal_embryo_hatching | 0.98957774 |
| 69 | MP0001851_eye_inflammation | 0.95988353 |
| 70 | MP0000343_altered_response_to | 0.93317870 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.93042378 |
| 72 | MP0009764_decreased_sensitivity_to | 0.91750424 |
| 73 | MP0010094_abnormal_chromosome_stability | 0.91347795 |
| 74 | MP0000858_altered_metastatic_potential | 0.90905885 |
| 75 | MP0003077_abnormal_cell_cycle | 0.89764330 |
| 76 | MP0001663_abnormal_digestive_system | 0.87990743 |
| 77 | MP0003690_abnormal_glial_cell | 0.87401036 |
| 78 | MP0003448_altered_tumor_morphology | 0.86333499 |
| 79 | MP0005164_abnormal_response_to | 0.86254844 |
| 80 | MP0005166_decreased_susceptibility_to | 0.83984742 |
| 81 | MP0000604_amyloidosis | 0.83839668 |
| 82 | MP0008004_abnormal_stomach_pH | 0.83336827 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.82780355 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.82508635 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.82054790 |
| 86 | MP0008057_abnormal_DNA_replication | 0.74587308 |
| 87 | MP0003828_pulmonary_edema | 0.74565236 |
| 88 | MP0003111_abnormal_nucleus_morphology | 0.74224757 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 0.74150195 |
| 90 | MP0000569_abnormal_digit_pigmentation | 0.73352570 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.72161390 |
| 92 | MP0000249_abnormal_blood_vessel | 0.71593417 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.68516822 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.67246999 |
| 95 | MP0003045_fibrosis | 0.67079895 |
| 96 | MP0009763_increased_sensitivity_to | 0.66126953 |
| 97 | MP0000313_abnormal_cell_death | 0.66057503 |
| 98 | MP0003795_abnormal_bone_structure | 0.65821399 |
| 99 | MP0002132_abnormal_respiratory_system | 0.65507838 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.63580124 |
| 101 | MP0002998_abnormal_bone_remodeling | 0.63093314 |
| 102 | MP0005390_skeleton_phenotype | 0.62644959 |
| 103 | MP0008874_decreased_physiological_sensi | 0.60204093 |
| 104 | MP0005023_abnormal_wound_healing | 0.58004494 |
| 105 | MP0005621_abnormal_cell_physiology | 0.57266910 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.55998855 |
| 107 | MP0003279_aneurysm | 0.55962209 |
| 108 | MP0002928_abnormal_bile_duct | 0.55628440 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.55368545 |
| 110 | MP0009931_abnormal_skin_appearance | 0.55211168 |
| 111 | MP0008873_increased_physiological_sensi | 0.53350881 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.50474547 |
| 113 | MP0000350_abnormal_cell_proliferation | 0.49723767 |
| 114 | MP0008260_abnormal_autophagy | 0.49646623 |
| 115 | MP0000609_abnormal_liver_physiology | 0.48765176 |
| 116 | MP0003091_abnormal_cell_migration | 0.47611056 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.45667627 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.45219249 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.43995311 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.41894045 |
| 121 | MP0009115_abnormal_fat_cell | 0.38314855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.58218279 |
| 2 | Cellulitis (HP:0100658) | 6.31104526 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.76896764 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.20979144 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.99057511 |
| 6 | Verrucae (HP:0200043) | 4.85768247 |
| 7 | Papilloma (HP:0012740) | 4.85768247 |
| 8 | Meningitis (HP:0001287) | 4.85378348 |
| 9 | Orchitis (HP:0100796) | 4.80567557 |
| 10 | Recurrent viral infections (HP:0004429) | 4.70708839 |
| 11 | Recurrent bronchitis (HP:0002837) | 4.63092449 |
| 12 | IgM deficiency (HP:0002850) | 4.60192912 |
| 13 | Colitis (HP:0002583) | 4.60024250 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.44552337 |
| 15 | Optic neuritis (HP:0100653) | 4.44552337 |
| 16 | Inflammation of the large intestine (HP:0002037) | 4.32019686 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 4.29306598 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 4.25181662 |
| 19 | Abnormality of B cell number (HP:0010975) | 4.18666203 |
| 20 | B lymphocytopenia (HP:0010976) | 4.18666203 |
| 21 | Recurrent fungal infections (HP:0002841) | 4.17199975 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.08723012 |
| 23 | Recurrent sinusitis (HP:0011108) | 3.98562267 |
| 24 | Osteomyelitis (HP:0002754) | 3.97350355 |
| 25 | Chronic otitis media (HP:0000389) | 3.92616425 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.89394760 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.85927759 |
| 28 | Obstructive lung disease (HP:0006536) | 3.77087690 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.77087690 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.64055656 |
| 31 | Recurrent skin infections (HP:0001581) | 3.59099457 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.58835142 |
| 33 | Recurrent pneumonia (HP:0006532) | 3.52278421 |
| 34 | Thyroiditis (HP:0100646) | 3.48606073 |
| 35 | Sepsis (HP:0100806) | 3.46975122 |
| 36 | Chronic sinusitis (HP:0011109) | 3.35372423 |
| 37 | Vasculitis (HP:0002633) | 3.31932094 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 3.31127607 |
| 39 | Lymphopenia (HP:0001888) | 3.29110650 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 3.26063854 |
| 41 | Abnormality of macrophages (HP:0004311) | 3.22643610 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.21188219 |
| 43 | Recurrent lower respiratory tract infections (HP:0002783) | 3.17367967 |
| 44 | Hypochromic anemia (HP:0001931) | 3.12617552 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 3.08555834 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.08555834 |
| 47 | Thrombocytosis (HP:0001894) | 3.05988194 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.98917611 |
| 49 | Emphysema (HP:0002097) | 2.95137926 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.92169795 |
| 51 | Restrictive lung disease (HP:0002091) | 2.89098113 |
| 52 | Small epiphyses (HP:0010585) | 2.86349688 |
| 53 | Myositis (HP:0100614) | 2.84080317 |
| 54 | Hemoptysis (HP:0002105) | 2.82309433 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80979683 |
| 56 | Pustule (HP:0200039) | 2.76399845 |
| 57 | Episodic fever (HP:0001954) | 2.70519380 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.63710358 |
| 59 | Gingivitis (HP:0000230) | 2.62098906 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.62048210 |
| 61 | Nasal polyposis (HP:0100582) | 2.56912889 |
| 62 | Petechiae (HP:0000967) | 2.56247009 |
| 63 | Purpura (HP:0000979) | 2.56176265 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55646277 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55646277 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55646277 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.55061000 |
| 68 | Bronchitis (HP:0012387) | 2.54997857 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.54789818 |
| 70 | Periodontitis (HP:0000704) | 2.53963569 |
| 71 | Increased IgM level (HP:0003496) | 2.53163680 |
| 72 | Pulmonary embolism (HP:0002204) | 2.49271294 |
| 73 | Anorexia (HP:0002039) | 2.47884692 |
| 74 | Recurrent otitis media (HP:0000403) | 2.47573085 |
| 75 | Skin ulcer (HP:0200042) | 2.47317627 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.44065488 |
| 77 | Amyloidosis (HP:0011034) | 2.43252669 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.42840657 |
| 79 | Eosinophilia (HP:0001880) | 2.38883756 |
| 80 | Skin rash (HP:0000988) | 2.38826291 |
| 81 | Abnormality of T cells (HP:0002843) | 2.38268737 |
| 82 | Urticaria (HP:0001025) | 2.38264098 |
| 83 | Mitral stenosis (HP:0001718) | 2.38104573 |
| 84 | Abnormality of the nasal mucosa (HP:0000433) | 2.37369071 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.33539622 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.33420114 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.31480510 |
| 88 | Microcytic anemia (HP:0001935) | 2.31210364 |
| 89 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.27986471 |
| 90 | Chest pain (HP:0100749) | 2.27226926 |
| 91 | IgA deficiency (HP:0002720) | 2.25416601 |
| 92 | Hematochezia (HP:0002573) | 2.25172924 |
| 93 | Abnormality of the fingertips (HP:0001211) | 2.22952258 |
| 94 | IgG deficiency (HP:0004315) | 2.22823773 |
| 95 | Increased serum ferritin (HP:0003281) | 2.21983887 |
| 96 | Leukocytosis (HP:0001974) | 2.21421013 |
| 97 | Increased IgE level (HP:0003212) | 2.19790283 |
| 98 | Stomatitis (HP:0010280) | 2.19529231 |
| 99 | Loss of speech (HP:0002371) | 2.19496738 |
| 100 | Neutropenia (HP:0001875) | 2.18594970 |
| 101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18299333 |
| 102 | Granulocytopenia (HP:0001913) | 2.18025625 |
| 103 | Epistaxis (HP:0000421) | 2.17430390 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 2.16849260 |
| 105 | Dysostosis multiplex (HP:0000943) | 2.13733670 |
| 106 | Lymphoma (HP:0002665) | 2.13623971 |
| 107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12720961 |
| 108 | Premature loss of primary teeth (HP:0006323) | 2.10806944 |
| 109 | Gangrene (HP:0100758) | 2.10076815 |
| 110 | Peritonitis (HP:0002586) | 2.09989132 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 2.08076201 |
| 112 | Viral hepatitis (HP:0006562) | 2.06362712 |
| 113 | Leukopenia (HP:0001882) | 2.06053639 |
| 114 | Systemic lupus erythematosus (HP:0002725) | 2.05670557 |
| 115 | Abnormal platelet volume (HP:0011876) | 2.05378306 |
| 116 | T lymphocytopenia (HP:0005403) | 2.03315891 |
| 117 | Pulmonary infiltrates (HP:0002113) | 2.01654859 |
| 118 | Glomerulopathy (HP:0100820) | 1.98362349 |
| 119 | Thoracic kyphosis (HP:0002942) | 1.97467763 |
| 120 | Encephalitis (HP:0002383) | 1.97324174 |
| 121 | Abnormality of T cell number (HP:0011839) | 1.96950497 |
| 122 | Impaired platelet aggregation (HP:0003540) | 1.95783948 |
| 123 | Abnormal platelet function (HP:0011869) | 1.95783948 |
| 124 | Combined immunodeficiency (HP:0005387) | 1.95442424 |
| 125 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94863251 |
| 126 | Hypertensive crisis (HP:0100735) | 1.94416894 |
| 127 | Papilledema (HP:0001085) | 1.92828672 |
| 128 | Severe combined immunodeficiency (HP:0004430) | 1.90878261 |
| 129 | Hypoplasia of the thymus (HP:0000778) | 1.89753404 |
| 130 | Gingival bleeding (HP:0000225) | 1.88007899 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.87368380 |
| 132 | Abnormality of the thoracic spine (HP:0100711) | 1.85966720 |
| 133 | Flattened epiphyses (HP:0003071) | 1.83102949 |
| 134 | Fatigue (HP:0012378) | 1.81694000 |
| 135 | Ulnar bowing (HP:0003031) | 1.78972023 |
| 136 | Arterial thrombosis (HP:0004420) | 1.77765025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.18843140 |
| 2 | MAP3K10 | 4.75409080 |
| 3 | ERN1 | 4.04936504 |
| 4 | BLK | 3.67215278 |
| 5 | GRK6 | 3.20677791 |
| 6 | RIPK4 | 3.15417818 |
| 7 | BTK | 2.62039825 |
| 8 | PRPF4B | 2.57528358 |
| 9 | CSF1R | 2.38263126 |
| 10 | IRAK4 | 2.28678217 |
| 11 | SYK | 2.28064658 |
| 12 | STK10 | 2.11700893 |
| 13 | EEF2K | 2.07136672 |
| 14 | FES | 2.04504742 |
| 15 | TYK2 | 1.89432894 |
| 16 | LRRK2 | 1.82910262 |
| 17 | SIK2 | 1.77194612 |
| 18 | TBK1 | 1.68572038 |
| 19 | TRIB3 | 1.66979018 |
| 20 | PKN2 | 1.57854350 |
| 21 | KIT | 1.56993937 |
| 22 | TEC | 1.53556343 |
| 23 | MAP3K3 | 1.51143428 |
| 24 | LYN | 1.49860976 |
| 25 | HCK | 1.49266321 |
| 26 | CSK | 1.46706429 |
| 27 | MAP3K14 | 1.46519958 |
| 28 | MAP3K13 | 1.41582400 |
| 29 | CLK1 | 1.40819281 |
| 30 | ZAP70 | 1.39643345 |
| 31 | TXK | 1.29630092 |
| 32 | MAP2K3 | 1.28570120 |
| 33 | TGFBR2 | 1.26024877 |
| 34 | MAP3K1 | 1.24030736 |
| 35 | IRAK3 | 1.23415349 |
| 36 | PIM1 | 1.17260139 |
| 37 | JAK1 | 1.14302750 |
| 38 | TAOK2 | 1.13145299 |
| 39 | NEK2 | 1.11789644 |
| 40 | SMG1 | 1.08587259 |
| 41 | EIF2AK3 | 1.07370553 |
| 42 | KSR2 | 1.06295936 |
| 43 | EPHB1 | 1.02844535 |
| 44 | IKBKB | 1.01803068 |
| 45 | LCK | 1.01158933 |
| 46 | CDK12 | 0.99075261 |
| 47 | CDK4 | 0.96357204 |
| 48 | IKBKE | 0.96221977 |
| 49 | JAK3 | 0.96065131 |
| 50 | MATK | 0.95547253 |
| 51 | MARK3 | 0.94760181 |
| 52 | ITK | 0.91513948 |
| 53 | TAOK3 | 0.91282008 |
| 54 | MAPK4 | 0.89921183 |
| 55 | YES1 | 0.88908999 |
| 56 | MARK2 | 0.88668341 |
| 57 | STK4 | 0.88600673 |
| 58 | TNK2 | 0.87228257 |
| 59 | CDK19 | 0.83057537 |
| 60 | BMPR2 | 0.81086755 |
| 61 | RPS6KA4 | 0.80817458 |
| 62 | IRAK1 | 0.77519320 |
| 63 | PDPK1 | 0.75451744 |
| 64 | IRAK2 | 0.75369671 |
| 65 | FGR | 0.72982252 |
| 66 | TESK2 | 0.70566454 |
| 67 | CDC42BPA | 0.68902435 |
| 68 | SCYL2 | 0.65784772 |
| 69 | SIK3 | 0.62920334 |
| 70 | PTK6 | 0.61734659 |
| 71 | MAP3K6 | 0.60486161 |
| 72 | MAPK7 | 0.59554256 |
| 73 | CAMK1D | 0.56130611 |
| 74 | MAP3K5 | 0.55885099 |
| 75 | HIPK2 | 0.54899714 |
| 76 | MAP3K11 | 0.52071069 |
| 77 | PIK3CG | 0.51470791 |
| 78 | ABL1 | 0.50822156 |
| 79 | CDK9 | 0.50644949 |
| 80 | JAK2 | 0.50582906 |
| 81 | TLK1 | 0.50206341 |
| 82 | MAP3K8 | 0.49743001 |
| 83 | ALK | 0.48553366 |
| 84 | PTK2B | 0.47734393 |
| 85 | RPS6KA6 | 0.47623046 |
| 86 | TRPM7 | 0.47243184 |
| 87 | DAPK2 | 0.46305224 |
| 88 | MAPK12 | 0.45996723 |
| 89 | MAP2K4 | 0.45623330 |
| 90 | MAPK11 | 0.45127329 |
| 91 | DYRK1B | 0.44588483 |
| 92 | KDR | 0.43439690 |
| 93 | PDK1 | 0.42705986 |
| 94 | RPS6KB2 | 0.42568849 |
| 95 | STK11 | 0.41654736 |
| 96 | RPS6KL1 | 0.41145606 |
| 97 | RPS6KC1 | 0.41145606 |
| 98 | FYN | 0.41114060 |
| 99 | CHUK | 0.39796452 |
| 100 | TTN | 0.39425551 |
| 101 | MAPKAPK2 | 0.39230026 |
| 102 | PRKCQ | 0.38619794 |
| 103 | MAP2K6 | 0.38539187 |
| 104 | CAMK1G | 0.38057250 |
| 105 | MAP3K7 | 0.37760837 |
| 106 | PRKCD | 0.37411105 |
| 107 | RET | 0.36796548 |
| 108 | PRKG2 | 0.36792481 |
| 109 | CDK6 | 0.36677938 |
| 110 | PIM2 | 0.35055589 |
| 111 | SIK1 | 0.34207161 |
| 112 | BRD4 | 0.34044842 |
| 113 | PRKCH | 0.33686129 |
| 114 | DYRK3 | 0.33607334 |
| 115 | FLT3 | 0.33164017 |
| 116 | FGFR4 | 0.32972491 |
| 117 | PRKD2 | 0.32172708 |
| 118 | GRK7 | 0.32060710 |
| 119 | EGFR | 0.31570161 |
| 120 | MAPKAPK3 | 0.31174061 |
| 121 | FGFR3 | 0.30916175 |
| 122 | SGK3 | 0.30164840 |
| 123 | PAK4 | 0.29791625 |
| 124 | BMX | 0.28223697 |
| 125 | PRKD1 | 0.27564342 |
| 126 | BCKDK | 0.26385039 |
| 127 | GRK1 | 0.26360319 |
| 128 | TAOK1 | 0.25939929 |
| 129 | MST4 | 0.24034767 |
| 130 | RAF1 | 0.23995141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.58819969 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.09614836 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92012850 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.69200758 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.55904386 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54838245 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.45980149 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42785643 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.29042718 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.18917555 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08010470 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02542130 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.98784473 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.98694116 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90898049 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.83717981 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79791269 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74660778 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63325468 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.61834448 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.59260612 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58285925 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.54015953 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53568609 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52078201 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.51108173 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.49956116 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48502207 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47752382 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47106684 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.43735765 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.35739978 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29108654 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28179374 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.25983428 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24934279 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24424996 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.24225409 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.22995456 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.21761126 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.21153727 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18864208 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18285653 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17747373 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15777160 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14341780 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10415941 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.09871235 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.06080663 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05072676 |
| 51 | Mismatch repair_Homo sapiens_hsa03430 | 1.05036329 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.04782291 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04636707 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04441269 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03388254 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 1.01968823 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99358480 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99136254 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94123860 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88285082 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86830656 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79945396 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77382184 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77199018 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76189647 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76023935 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74818940 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74583497 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.69535921 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67670387 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66896074 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66289086 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.66069979 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65970610 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64264035 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.64159682 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64157534 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61378646 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59440921 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55992914 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55482379 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55180855 |
| 83 | Spliceosome_Homo sapiens_hsa03040 | 0.53191483 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.52106872 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.51561108 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49613581 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48559350 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46559351 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45659611 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45089379 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45037047 |
| 92 | Cell cycle_Homo sapiens_hsa04110 | 0.44720625 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44062751 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43882625 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.42858164 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41709640 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41392311 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.40947690 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40316715 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39294412 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38633086 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37856909 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37255071 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35942767 |
| 105 | Allograft rejection_Homo sapiens_hsa05330 | 0.35685052 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33773955 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.33339848 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32859739 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32760356 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32744670 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31892755 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31475990 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31318703 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31182990 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31081447 |
| 116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29825302 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29049885 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28696306 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28425909 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.27575063 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26919158 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.24902178 |

